Curevac : Curevac and European Commission in Advanced Discussions to Supply up to 405 Million Doses of Potential MRNA-Based COVID-19 Vaccine
TÜBINGEN, GERMANY / BOSTON, MA / ACCESSWIRE / August 20, 2020 / CureVac, a clinical-stage biopharmaceutical company, developing a new...